Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year

Business by 2FIRSTS
Aug.05.2024
Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year
Altria Group releases strong Q2 results for on! nicotine pouches and NJOY products, showing consistent growth in sales.

Recently, Altria Group, Inc. released its performance report for the second quarter and first half of 2024. In the second quarter, the shipment volume of on! nicotine pouches reached 41.2 million cans, an increase of 37.3% compared to the same period last year. Additionally, the total shipment volume of NJOY consumables and devices in the second quarter reached 14.3 million units.

 

2FIRSTS analyzed the market performance of Altria's nicotine pouch and NJOY over the past year, aiming to provide in-depth insights into their prospects in the smokeless tobacco/e-cigarette market.

 

Sales Volume of Nicotine Pouches Continues to Rise in Q4

 

The performance report for the second quarter and first half of 2024 from Altria Group indicates that the on! nicotine pouch, as a smokeless nicotine product, has seen consecutive growth in both shipments and market share in the U.S. oral tobacco market for four consecutive quarters.

 

Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year
Mapping: 2FIRSTS

 

In particular, in the second quarter of this year, the total shipment volume of ON! nicotine pouches reached 41.2 million cans, an increase of 37.3% compared to the same period last year. They held a market share of 8.10% in the U.S. oral tobacco market, with a growth rate of 1.20% compared to the previous year.

 

In the first quarter of this year, ON! Nicotine pouches' total shipment volume reached 33.3 million cans, a YoY increase of 32.1%; occupying a 7.10% market share in the U.S. oral tobacco market, with a YoY growth rate of 0.70%.

 

Looking back at the fourth quarter of 2023, the total shipment volume of on! nicotine pouches was 30.4 million cans, an increase of 32.8% year-on-year. The market share was 6.90%, with a year-on-year growth rate of 1.10%.

 

In the third quarter of 2023, the total shipment volume of ON! nicotine pouches was 28.7 million cans, a year-on-year increase of 36.7%, with a market share of 6.90%, representing a year-on-year growth rate of 1.70%.

 

Up until the first half of 2024, the shipping volume of on! nicotine pouches has increased by 35% year-on-year.

 

Over the past four quarters, the shipment volume of ON! nicotine pouches has maintained a year-on-year growth rate of over 30%, and its overall market share has also been on the rise. Although the market share of the product in the U.S. smokeless tobacco market saw a decrease in the first quarter of this year compared to the same period last year, in the second quarter, both the shipment volume, year-on-year growth rate, and market share of ON! nicotine pouches reached their highest point in two years.

Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year
Mapping: 2FIRSTS

2FIRSTS compared the market performance of On! nicotine pouches with ZYN, a nicotine pouch under the Phillip Morris International (PMI) brand, over the past year.

 

From the third quarter of 2023 to the first half of 2024, ZYN nicotine pouches have achieved four consecutive quarters of growth in the US market. Although the year-on-year and quarter-on-quarter growth rates decreased in the second quarter of 2024, the overall growth momentum remains strong. By the first half of 2024, the shipment volume of ZYN nicotine pouches has increased by 63.5% year-on-year.

 

Nicotine pouches, as a smokeless nicotine product, have gained high acceptance among American consumers, and this type of product has already achieved a significant market share in the American market.

 

NJOY Retail Market Share Reached 5.50%

 

Altria Group's Q2 Performance: On! Nicotine Pouches Achieve Best Sales in a Year
Mapping: 2FIRSTS

 

On June 1, 2023, Altria Group completed its acquisition of NJOY, achieving growth in sales by strengthening NJOY's global supply chain, filling retail inventory gaps, and expanding distribution channels.

 

Specifically, in the third quarter of 2023, NJOY's total shipment of devices and consumables reached 7.5 million units. By the fourth quarter of 2023, the shipment volume increased to 12 million units, representing a 60% quarter-on-quarter growth. At the same time, NJOY's market share in the United States rose to 3.70%.

 

In the first quarter of 2024, NJOY's shipment volume of devices and consumables slightly increased to 11.9 million units, representing a 0.6% increase from the previous quarter. The retail market share also further increased to 4.30%.

 

In the second quarter of 2024, the shipping volume significantly increased to 14.3 million units, a sequential growth of 1.3%, with a retail market share reaching 5.50% and a continued growth in market share.

 

According to the data, NJOY maintained growth in shipments from the fourth quarter of 2023 to the second quarter of 2024, while steadily increasing its retail market share in the U.S. e-cigarette market.

 

Altria Group's second quarter and first half performance report also showed that in the first half of 2024, the group's net revenue decreased by 3.6% to $11.8 billion, with revenue excluding excise taxes decreasing by 2.0% to $10 billion. The main reason for the decline in revenue was a decrease in revenue from the smokeable products segment, but this was partially offset by an increase in revenue from the oral tobacco products segment.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
U.S. Health Groups Seek to Overturn FDA Enforcement Discretion for Pending PMTAs as Altria's Helix, NJOY and AVM Move to Intervene
American Vapor Manufacturers (AVM) and Altria subsidiaries Helix Innovations and NJOY filed separate motions on October 7, 2026, seeking to intervene on the FDA's side in a lawsuit challenging its enforcement guidance for certain e-cigarette and nicotine pouch products with pending premarket tobacco product applications (PMTAs). Seven public health and tobacco-control organizations, including the Campaign for Tobacco-Free Kids, sued the agency in July to overturn the policy. AVM argues that vacating the guidance could disrupt orders, inventory, retail distribution and investments in regulatory submissions.
Regulations
Oct.09
Canada Recalls Nearly 25,000 GTMBAR Vapes Over Child-Resistant Packaging Violations; Brand Linked to Shenzhen GTM Bar, with LK Vape as Importer and Distributor
Canada Recalls Nearly 25,000 GTMBAR Vapes Over Child-Resistant Packaging Violations; Brand Linked to Shenzhen GTM Bar, with LK Vape as Importer and Distributor
Health Canada announced a recall of 24,950 China-made GTMBAR 45K disposable vaping devices on November 13, 2026, citing non-compliance with child-resistant packaging requirements. The devices were sold in Canada between December 2024 and October 2026 and feature a 20mL e-liquid system with a nicotine concentration of 20 mg/mL. No related incidents or injuries had been reported as of November 12. Quebec-based LK Vape is the Canadian importer and distributor, while Shenzhen GTM bar Electronic Technology Co., Ltd. holds the GTMBAR trademark registration in the United Kingdom.
Regulations
Nov.16
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
Special Report | Altria's NACS Booth Raises Questions Over U.S. Tobacco Advertising Warnings
During its coverage of Altria's booth at NACS Show 2026, 2Firsts documented product displays that prompted questions about U.S. tobacco advertising warning requirements. Following public comments from a former FDA official, 2Firsts sought responses from Altria and independently consulted U.S. regulatory lawyer Azim Chowdhury. Altria maintained that its B2B communications complied with applicable laws, while Chowdhury explained that federal warning rules provide no general trade-show exemption for e-cigarettes and nicotine pouches. The special report examines the broader regulatory implications.
Nov.04
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives